β2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin
- 1 October 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 336 (8720) , 951-953
- https://doi.org/10.1016/0140-6736(90)92330-k
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Use of an Enzyme-Linked Immunosorbent Assay and of Inhibition Studies to Distinguish Between Antibodies to Cardiolipin from Patients with Syphilis or Autoimmune DisordersThe Journal of Infectious Diseases, 1988
- Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-IBiochimica et Biophysica Acta (BBA) - General Subjects, 1986